Diminished susceptibility to in vitro oxidation of low-density lipoproteins in hypercholesterolemia: Key role of alpha-tocopherol content

Atherosclerosis

Volumn 144, Issue 1, 1999, Pages 103-107

  Leonhardt, Wolfgang ^a   Hanefeld, Markolf ^b   Schaper, Frank ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NONE

Author keywords

Tocopherol; Hypercholesterolemia; Lagtime; LDL composition; LDL oxidation; Lipoperoxides; Malondialdehyde

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; CHOLESTEROL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID COMPOSITION; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADULT; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERENCE VALUES; REGRESSION ANALYSIS; TIME FACTORS; VITAMIN E;

EID: 0032974587     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00039-8     Document Type: Article

References (25)

1. Stalenhoef AFH. Clinical implications of increased low-density lipoprotein oxidation in patients with hypercholesterolemia. Nutrition 1994;10:564-6.
2. Cominacini L, Pastorino AM, Garbin U, Campagnola M, Desantis A, Davoli A, Faccini G, Bertozzo L, Pasini F, Pasini AF, Locascio V. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients. Nutrition 1994;10:527-31.
3. Napoli C, Postiglione A, Triggiani M, Corso G, Palumbo G, Carbone V, Ruocco A, Ambrosio G, Montefusco S, Malorni A, Condorelli M, Chiariello M. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Atherosclerosis 1995;118:259-73.
4. Stalenhoef AFH, Defesche JC, Kleinveld HA, Demacker PNM, Kastelein JJP. Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100. Arterioscler Thromb 1994;14:489-93.
5. Mosinger BJ. Copper-induced and photosensitive oxidation of serum low-density lipoprotein. The relation to cholesterol level and inter-species differences. Biochim Biophys Acta 1995;1270:73-80.
6. Lavy A, Brook GJ, Dankner G, Ben-Amotz A, Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991;40:794-9.
7. Raal FJ, Areias AJ, Waisberg R, Vonarb M. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia. Atherosclerosis 1995;115:9-15.
8. Gilligan DM, Sack MN, Guetta V, Casino PR, Quyyumi AA, Rader DJ, Panza JA, Cannon RO. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994;24:1611-7.
9. Mehmetcik G, Toker G, Uysal M. Endogenous and copper-induced lipid peroxidation and antioxidant activity of serum in hypercholesterolemic subjects. Horm Metab Res 1996;29:63-5.
10. Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993;94:350-6.
11. Leonhardt W, Pietzsch J, Nitzsche S. Very-fast ultracentrifugation of human plasma lipoproteins-influence of the centrifugal field on lipoprotein composition. Clin Chim Acta 1994;224:21-32.
12. Pietzsch J, Subat S, Nitzsche S, Leonhardt W, Schentke KU, Hanefeld M. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition. Biochim Biophys Acta 1995;1254:77-88.
13. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radie Res Commun 1989;6:67-75.
14. Gieseg SP, Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEES Lett 1994;343:188-94.
15. Sanz DC, Santa-Cruz MC. Simultaneous measurement of retinol and a-tocopherol in human serum by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1986;380:140-4.
16. Nourooz-Zadeh J, Tajaddinisarmadi J, Wolff SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994;220:403-9.
17. Puhl H, Waeg G, Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Oxygen radicals in biological systems. Methods Enzymol 1994;233:425-41.
18. Esterbauer H, Gebicky J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radie Biol Med 1992;13:341-90.
19. Kuzuya M, Yamada K, Hayashi T, Funaki C, Naito M, Asai K, Kuzuya F. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochim Biophys Acta 1992;! 123:334-41.
20. Reaven PD, Herold DA, Barnett J, Edelman S. Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotoin subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 1995;18:807-16.
21. Fuller CJ, Chandalia M, Garg A, Grundy SM, Jialal I. RRR-alpha-tocopheryl acetate supplementation at pharmacologie doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus. Am J Clin Nutr 1996;63:753-9.
22. Bittolo-Bon G, Cazzolato G, Avogaro P. Probucol protects low-density lipoproteins from in vitro and in vivo oxidation. Pharmacol Res 1994;29:337-44.
23. de-Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991;11:298-306.
24. Kontush A, Finckh B, Karten B, Kohlschutter A, Beisiegel U. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein. J Lipid Res 1996;37:1436-48.
25. de Rijke YB, Bredie SJH, Demacker PNM, Vogelaar JM, HakLemmers HLM, Stalenhoef AFH. The redox status of coenzyme Q10 in total LDL as an indicator of in vivo oxidative modification- studies on subjects with familial combined hyperlipidemia. Arterioscler Thromb Vase Biol 1997;17:127-33.